Jason Criscione, PhD

Chief Scientific Officer

Dr. Criscione is an applied science and engineering entrepreneur with more than 10 years of experience in drug delivery and a unique expertise that covers chemistry, materials science, physics, biophysics, and biomedical engineering.  Dr. Criscione has experience in building interdisciplinary technical teams and leading the discovery, R&D, preclinical studies, CRO management, CDMO management, scientific writing, intellectual property writing and portfolio management, process development, equipment design and selection, clean room and facility design, scale-up efforts, analytical development, and CMC for start-up biotech and pharmaceutical companies.

Dr. Criscione has published in numerous peer-reviewed, scientific journals, including, Nature Nanotechnology, Nature Materials, Biomaterials, JACS, ACS Nano, and Bioconjugate Chemistry.

Dr. Criscione received his PhD in Biomedical Engineering from Yale University. He also holds a MPhil in Biomedical Engineering from Yale University, a MS in Biomedical Engineering from Yale University, a MS in Physical Chemistry from Michigan State University, and a BA with High Honors in Chemistry and a concentration in Neuroscience from Oberlin College.